Literature DB >> 16570152

Bone marrow necrosis associated with the use of imatinib mesylate in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Kosei Matsue, Masami Takeuchi, Mihoko Koseki, Hidetaka Uryu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16570152     DOI： 10.1007/s00277-005-0071-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  4 in total

1.  Extensive bone marrow necrosis resolved by allogeneic umbilical cord blood mesenchymal stem cell transplantation in a chronic myeloid leukemia patient.

Authors:  Y Pan; X Wang; C Wang; Q Zhang; R Xi; J Bai; H Bai
Journal:  Bone Marrow Transplant       Date:  2015-05-11       Impact factor: 5.483

Review 2.  Hematologic toxicities of small molecule tyrosine kinase inhibitors.

Authors:  Nicholas A Barber; Wais Afzal; Mojtaba Akhtari
Journal:  Target Oncol       Date:  2011-11-30       Impact factor: 4.493

Review 3.  Imatinib: in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Authors:  Sarah A Cross; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Imatimid-induced bone marrow necrosis detected on MRI examination and mimicking bone metastases.

Authors:  D Vanel; S Bonvalot; C Le Pechoux; A Cioffi; J Domont; A Le Cesne
Journal:  Skeletal Radiol       Date:  2007-06-23       Impact factor: 2.199
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.